N@N

by Source: (remove) : Irina Rivkind Koffler
^{RSS • JSON • XML • CSV}

Irina Rivkind Koffler Maintained (SUPN) at Strong Buy with Increased Target to $63 on, Dec 17th, 2018

^{Published on 2024-10-26 11:18:11 - WOPRAI, Irina Rivkind Koffler}
 

Irina Rivkind Koffler of Mizuho, Maintained "Supernus Pharmaceuticals, Inc." (SUPN) at Strong Buy with Increased Target from $61 to $63 on, Dec 17th, 2018.

Irina has made no other calls on SUPN in the last 4 months.

There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, 0 agree with Irina's Rating of Hold.

This is the rating of the analyst that currently disagrees with Irina

---

• David Buck of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $65 on, Monday, November 12th, 2018

Contributing Sources

---